EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel Inhibitors of SARS-CoV-2 RNA Identified through Virtual Screening

Gregory Mathez iD, Andrea Brancale iD, Valeria Cagno iD

Journal of Chemical Information and Modeling · 2024

DOI: 10.1021/acs.jcim.4c00758 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Chemical Information and Modeling, 2024. Verfasst von Gregory Mathez und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Microbiology, University Hospital of Lausanne, University of Lausanne, 1011 Lausanne, Switzerland. Hauptthemen laut MEDLINE: SARS-CoV-2, Antiviral Agents, RNA, Viral, Drug Evaluation, Preclinical. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission, Schweizerischer Nationalfonds zur F?rderung der Wissenschaftlichen Forschung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We currently lack antivirals for most human viruses. In a quest for new molecules, focusing on viral RNA, instead of viral proteins, can represent a promising strategy. In this study, new inhibitors were identified starting from a published crystal structure of the tertiary SARS-CoV-2 RNA involved in the -1 programmed ribosomal frameshift. The pseudoknot structure was refined, and a virtual screening was performed using the repository of binders to the nucleic acid library, taking into consideration RNA flexibility. Hit compounds were validated against the wild-type virus and with a dual-luciferase assay measuring the frameshift efficiency. Several active molecules were identified. Our study reveals new inhibitors of SARS-CoV-2 but also highlights the feasibility of targeting RNA starting from virtual screening, a strategy that could be broadly applied to drug development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2Antiviral AgentsRNA, ViralDrug Evaluation, PreclinicalHumansNucleic Acid ConformationMolecular Docking SimulationUser-Computer InterfaceModels, Molecular

Substanzen

Antiviral AgentsRNA, Viral

Autor:innen und Institutionen

  • Institute of Microbiology, University Hospital of Lausanne, University of Lausanne, 1011 Lausanne, Switzerland.
  • Department of Organic Chemistry, University of Chemistry and Technology Prague, 16628 Prague 6, Czech Republic.

ORCID-Profile: Gregory Mathez, Andrea Brancale, Valeria Cagno

Förderung

  • European Commission
  • Schweizerischer Nationalfonds zur F?rderung der Wissenschaftlichen Forschung

Zitieren

APA

Mathez, G., Brancale, A., & Cagno, V. (2024). Novel Inhibitors of SARS-CoV-2 RNA Identified through Virtual Screening. Journal of Chemical Information and Modeling. https://doi.org/10.1021/acs.jcim.4c00758

Vancouver

Mathez G, Brancale A, Cagno V. Novel Inhibitors of SARS-CoV-2 RNA Identified through Virtual Screening. Journal of Chemical Information and Modeling. 2024. doi:10.1021/acs.jcim.4c00758

BibTeX
@article{Mathez2024,
  author = {Mathez, Gregory and Brancale, Andrea and Cagno, Valeria},
  title = {Novel Inhibitors of SARS-CoV-2 RNA Identified through Virtual Screening},
  journal = {Journal of Chemical Information and Modeling},
  year = {2024},
  doi = {10.1021/acs.jcim.4c00758}
}
Kostenlos starten →